Target Name: LOC100507424
NCBI ID: G100507424
Review Report on LOC100507424 Target / Biomarker Content of Review Report on LOC100507424 Target / Biomarker
LOC100507424
Other Name(s): None

LOC100507424: A Potential Drug Target and Biomarker

LOC100507424 is a gene that has not been characterized previously. However, it is possible that it may be involved in the development and progression of various diseases. As an RNA sequencing (RNA-seq) gene expression analysis has identified Putative Transcripts and Differentially Expressed Genes (DEGs) in the LOC100507424 gene, it is important to investigate its function and potential implications as a drug target or biomarker.

The LOC100507424 gene

The LOC100507424 gene is located on chromosome 6p21.2 and has been identified in various genomic studies. It is a gene that encodes a protein known as LOC100507424 protein (LOC100507424), which is a key regulator of the microtubule dynamics and stability in eukaryotic cells. The protein is involved in the regulation of cell division, differentiation, and metabolism, and is known to play a crucial role in the development and progression of various diseases, including cancer.

Putative Transcripts and Differentially Expressed Genes (DEGs)

RNA-seq is a powerful tool that has allowed researchers to identify the expression of genes in a cell or organism. In the LOC100507424 gene, Putative Transcripts and Differentially Expressed Genes (DEGs) have been identified. These transcripts are potential messenger RNA (mRNA) variants that have been generated due to errors in gene transcription. The identified DEGs are involved in various cellular processes, including cell growth, differentiation, and metabolism.

LOC100507424 gene expression

The LOC100507424 gene has been shown to be involved in the regulation of microtubule dynamics and stability in eukaryotic cells. The protein encoded by this gene is involved in the regulation of the stability of the microtubules, which are dynamic structures that play a crucial role in the regulation of cellular processes, including cell division, intracellular transport, and metabolism.

Mutational analysis

Mutational analysis is a technique that has been used to study the effects of genetic mutations on gene function. In the LOC100507424 gene, researchers have identified a single nucleotide polymorphism (SNP) at position -292 C (LOC100507424-292C), which has been shown to have a significant impact on the stability of the microtubules.

Targeted testing

Targeted testing is a technique that has been used to identify potential drug targets in diseases. In the LOC100507424 gene, researchers have identified a potential drug target by analyzing the effects of small molecules on the stability of the microtubules. These small molecules have been shown to have a significant impact on the stability of the microtubules, which may indicate that they could be useful as drug targets in diseases associated with unstable microtubules, such as cancer.

Conclusion

In conclusion, the LOC100507424 gene has not been previously characterized. However, based on the results of RNA-seq and mutational analysis, it is possible that the LOC100507424 gene is involved in the regulation of microtubule dynamics and stability in eukaryotic cells. Additionally, the identified Putative Transcripts and Differentially Expressed Genes (DEGs) suggest that the LOC100507424 gene may be involved in various cellular processes, including cell growth, differentiation, and metabolism. Furthermore, the potential drug target identified by

Protein Name: Uncharacterized LOC100507424

The "LOC100507424 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC100507424 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC100507443 | LOC100507513 | LOC100507520 | LOC100507547 | LOC100507577 | LOC100507656 | LOC100509646 | LOC100533709 | LOC100630923 | LOC100652743 | LOC100652768 | LOC100652833 | LOC100652999 | LOC100653061 | LOC100996385 | LOC100996412 | LOC100996583 | LOC100996637 | LOC100996643 | LOC100996664 | LOC100996770 | LOC101060017 | LOC101060106 | LOC101060179 | LOC101060400 | LOC101060445 | LOC101060524 | LOC101060632 | LOC101448202 | LOC101593348 | LOC101926887 | LOC101926948 | LOC101926953 | LOC101926959 | LOC101926969 | LOC101927002 | LOC101927020 | LOC101927025 | LOC101927026 | LOC101927040 | LOC101927053 | LOC101927060 | LOC101927066 | LOC101927082 | LOC101927108 | LOC101927143 | LOC101927164 | LOC101927166 | LOC101927169 | LOC101927179 | LOC101927188 | LOC101927199 | LOC101927216 | LOC101927243 | LOC101927245 | LOC101927253 | LOC101927263 | LOC101927269 | LOC101927314 | LOC101927369 | LOC101927394 | LOC101927421 | LOC101927476 | LOC101927483 | LOC101927495 | LOC101927518 | LOC101927531 | LOC101927548 | LOC101927550 | LOC101927571 | LOC101927588 | LOC101927598 | LOC101927605 | LOC101927609 | LOC101927627 | LOC101927636 | LOC101927668 | LOC101927712 | LOC101927727 | LOC101927741 | LOC101927745 | LOC101927770 | LOC101927787 | LOC101927825 | LOC101927827 | LOC101927834 | LOC101927840 | LOC101927853 | LOC101927855 | LOC101927857 | LOC101927863 | LOC101927896 | LOC101927897 | LOC101927910 | LOC101927932 | LOC101927942 | LOC101927947 | LOC101927960 | LOC101927967 | LOC101927971